The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Diabetic Retinopathy and VEGF
Open accessAbstract
Diabetic retinopathy remains the leading vascular-associated cause of blindness throughout the world. Its treatment requires a multidisciplinary interventional approach at both systemic and local levels. Current management includes laser photocoagulation, intravitreal steroids, and anti-vascular endothelial growth factor (VEGF) treatment along with systemic blood sugar control. Anti-VEGF therapies, which are less destructive and safer than laser treatments, are being explored as primary therapy for the management of vision-threatening complications of diabetic retinopathy such as diabetic macular edema (DME). This review provides comprehensive information related to VEGF and describes its role in the pathogenesis of diabetic retinopathy, and in addition, examines the mechanisms of action for different antiangiogenic agents in relation to the management of this disease. Medline (Pubmed) searches were carried out with keywords “VEGF”, “diabetic retinopathy”, and “diabetes” without any year limitation to review relevant manuscripts used for this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Ranibizumab for Diabetic Macular Edema
Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A. C., Hopkins, J. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.039 · Cited by 1,621
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
Holmes, K., Roberts, O. L., Thomas, A. M., & Cross, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.013 · Cited by 1,020
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., & Sato, M. (1990) · PubMed · Cited by 960
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., & Berse, B. (1994) · PubMed · Cited by 810
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Massin, P., Bandello, F., Garweg, J. G., Hansen, L. L., Harding, S. P., Larsen, M., Mitchell, P., Sharp, D., Wolf-Schnurrbusch, U. E. K., Gekkieva, M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0493 · Cited by 720
Antonetti, D. A., Barber, A. J., Hollinger, L. A., Wolpert, E. B., & Gardner, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23463 · Cited by 686
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia
Levy, A. P., Levy, N. S., & Goldberg, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2746 · Cited by 629
Jw, M. (1994) · UCL Discovery (University College London) · Cited by 584
Elman, M. J., Bressler, N. M., Qin, H., Beck, R. W., Ferris, F. L., Friedman, S. M., Glassman, A. R., Scott, I. U., Stockdale, C. R., & Sun, J. K. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.033 · Cited by 573
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Nguyen, Q. D., Shah, S. M., Khwaja, A. A., Channa, R., Hatef, E., Do, D. V., Boyer, D., Heier, J. S., Abraham, P., Thach, A. B., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.016 · Cited by 532
Michaelides, M., Kaines, A., Hamilton, R. D., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C. J., Xing, W., Egan, C., Peto, T., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.045 · Cited by 521
Nauck, M., Karakiulakis, G., Perruchoud, A. P., Papakonstantinou, E., & Roth, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01464-7 · Cited by 479
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.062 · Cited by 451
Michaelson, I. (1948) · Medical Entomology and Zoology · Cited by 448
Bresnick, G. H. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33650-9 · Cited by 410
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Heier, J. S., Antoszyk, A. N., Pavan, P. R., Leff, S. R., Rosenfeld, P. J., Ciulla, T. A., Dreyer, R. F., Gentile, R. C., Sy, J. P., Hantsbarger, G., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.052 · Cited by 360
Nguyen, Q. D., Shah, S. M., Heier, J. S., Do, D. V., Lim, J., Boyer, D., Abraham, P., & Campochiaro, P. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.023 · Cited by 340
Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.913 · Cited by 301
DANSER, A. H. J., VAN DEN DORPEL, M. A., DEINUM, J., DERKX, F. H. M., FRANKEN, A. A. M., PEPERKAMP, E., DE JONG, P. T. V. M., & SCHALEKAMP, M. A. D. H. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-160 · Cited by 281
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
Fabbro, D., Ruetz, S., Bodis, S. B., Pruschy, M. N., Csermak, K., Man, A., Campochiaro, P. A., Wood, J. M., O'Reilly, T., & Meyer, T. (2000) · PubMed · Cited by 271
The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Do, D. V., Schmidt-Erfurth, U., Gonzalez, V. H., Gordon, C. M., Tolentino, M., Berliner, A. J., Vitti, R., Rückert, R., Sandbrink, R., Stein, D., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.018 · Cited by 253
HIF-1: Using Two Hands to Flip the Angiogenic Switch
Semenza, G. L. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026544214667 · Cited by 248
Nauck, M., Roth, M., Tamm, M., Eickelberg, O., Wieland, H., Stulz, P., & Perruchoud, A. P. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.4.9115750 · Cited by 241
Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
Propper, D. J., McDonald, A. C., Man, A., Thavasu, P., Balkwill, F., Braybrooke, J. P., Caponigro, F., Graf, P., Dutreix, C., Blackie, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1485 · Cited by 233
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
Simó, R., & Hernández, C. (2008) · Diabetologia · doi:10.1007/s00125-008-0989-9 · Cited by 228
Role of the pericyte in wound healing
Crocker, D. J., Murad, T. M., & Geer, J. C. (1970) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(70)90084-5 · Cited by 218
The PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
Oshima, Y., Sakaguchi, H., Gomi, F., & Tano, Y. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.02.015 · Cited by 197
Yoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Tsujinoue, H., Nakatani, T., Shibuya, M., et al. (1999) · PubMed · Cited by 183
Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00129-8 · Cited by 178
Sultan, M. B., Zhou, D., Loftus, J., Dombi, T., & Ice, K. S. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.045 · Cited by 172
Funatsu, H., Yamashita, H., Ikeda, T., Nakanishi, Y., Kitano, S., & Hori, S. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01323-5 · Cited by 169
Effect of Ruboxistaurin in Patients With Diabetic Macular Edema
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.318 · Cited by 151
Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro, P. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0955 · Cited by 144
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Diabetic macular edema, Risk factors and concomitants
de Faria, J. M. L., Jalkh, A. E., Trempe, C. L., et al. (1999) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1999.770211.x · Cited by 133
Aiello, L. P., Beck, R. W., Bressler, N. M., Browning, D. J., Chalam, K. V., Davis, M. D., Ferris, F. L., Glassman, A. R., Maturi, R. K., Stockdale, C. R., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.058 · Cited by 116
Marshall, G., Garg, S. K., Jackson, W. E., Holmes, D. L., & Chase, H. P. (1993) · Ophthalmology · doi:10.1016/s0161-6420(13)31517-6 · Cited by 106
Diana, V., Nguyen, Q. D., Shah, S. M., Browning, D. J., Haller, J. A., Chu, K. W., Yang, K., Cedarbaum, J. M., Vitti, R., Ingerman, A., et al. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.138271 · Cited by 98
PANRETINAL PHOTOCOAGULATION AND RETINAL OXYGENATION
Landers, M. B., Stefánsson, E., & Wolbarsht, M. L. (1982) · Retina · doi:10.1097/00006982-198200230-00007 · Cited by 89
Pharmacotherapy for diabetic retinopathy
Comer, G. M., & Ciulla, T. A. (2004) · Current Opinion in Ophthalmology · doi:10.1097/01.icu.0000143685.60479.3b · Cited by 74
Dose‐ and Time‐Dependent Pharmacokinetics of Midostaurin in Patients With Diabetes Mellitus
Wang, Y., Yin, O. Q. P., Gräf, P., Kisicki, J. C., & SCHRAN, H. F. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008318006 · Cited by 48
&NA; (2008) · Drugs in R&D · doi:10.2165/00126839-200809040-00006 · Cited by 32
OPHTHALMIC FINDINGS AMONG ONE THOUSAND INHABITANTS OF RAROTONGA, COOK ISLANDS
Heriot, W. J., Crock, G. W., TAYLOR, R., et al. (1983) · Australian Journal of Opthalmology · doi:10.1111/j.1442-9071.1983.tb01057.x · Cited by 24
DIABETIC RETINOPATHY IN A NATURAL POPULATION
MB, W. J. H., FRACO, J. P. B., FRACP, P. Z., et al. (1983) · Australian Journal of Opthalmology · doi:10.1111/j.1442-9071.1983.tb01075.x · Cited by 17
Vitrectomy Surgery for Diabetic Retinopathy
Bresnick, G. H., & Myers, F. L. (1979) · Annual Review of Medicine · doi:10.1146/annurev.me.30.020179.001555 · Cited by 2
Cited by
Alam, S., Hasan, M. K., Neaz, S., Hussain, N., Hossain, M. F., & Rahman, T. (2021) · Diabetology · doi:10.3390/diabetology2020004 · Cited by 323
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Liu, F., Ma, Y., & Xu, Y. (2020) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191018122821 · Cited by 26
Metadata
- Authors
- Gupta, N., Mansoor, S., Sharma, A., Sapkal, A., Sheth, J., Falatoonzadeh, P., Kuppermann, B., & Kenney, M.
- Venue
- The Open Ophthalmology Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-02-01
- Volume
- 7
- Issue
- 1
- Pages
- 4-10
- ISSN
- 1874-3641 (ISSN-L)
- OpenAlex
- W2040168311
- Cited by
- 285
- References
- 74
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.